Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Prevention of CFRD
NCT00967798Phase 3Terminated
- Sponsor
- Emory University
- Start
- May 2010
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in cystic fibrosis-related diabetes (CFRD), sponsored by Emory University. Started May 2010; status: terminated.
02
Drugs
sitagliptin
03
Conditions
cystic fibrosis-related diabetes (CFRD)
Beyond the preview
Go deeper on NCT00967798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967798.